TVG Publications

Posters

2009

Immunostimulatory Effects of Polysaccharide Krestin Are Mediated via TLR2
Persistent Immunity and Survival after Immunization with a HER-2/neu (HER2) Vaccine
DNA Based Vaccines Induce Protective Anti-tumor Immunity Against the Lung Cancer Antigen Insulin Like Growth Factor Binding Protein-2
A Phase I Study of a DNA Plasmid Based Vaccine Encoding the HER-2/neu (HER2) Intracellular Domain (ICD) in Subjects with HER2+ Breast Cancer
Development of HER-2/neu (HER2)-specific T Cell Immunity in Patients with HER2-positive Inflammatory Breast Cancer (IBC) May Impact Prognosis
The level of HER-2/neu (HER2) gene amplification in breast cancer impacts the persistence of antigen specific T cell immunity achieved after HER2 vaccination
Phase 1 study of infusion of HER-2/neu specific T cells in patients with advanced stage HER-2/neu overexpressing cancers who have received a HER-2/neu vaccine
Enhancing HER2/neu Specific T-cell Therapy by Targeting the Tumor Endothelium

2008

Targeting HER2-Specific CD4+ Th1 Cells to Tumors to Induce CD8+ T Cell-Mediated Tumor Rejection
Immunomodulation by PSK Augments the Anti-tumor Effect of Paclitaxel in Mice with Locally Advanced Breast Cancers

Pages